ArticleFrontiers in public health2023

Prevalence and cost of sickle cell disease in France: real-world analysis using data from the Echantillon Généraliste des Bénéficiaires.

Maud Beillat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.